Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Phase I/II Clinical Study Assessing the Safety and Tolerability of APO866 in Patients With Refractory B-cell Lymphocytic Leukaemia Not Amenable to Allogeneic Hemopoietic Stem Cell Transplantation

NCT00435084 is registered in ClinicalTrials.gov with Valerio Therapeutics as lead sponsor.

NCT NCT00435084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00435084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Phase I/II Clinical Study Assessing the Safety and Tolerability of APO866 in Patients With Refractory B-cell Lymphocytic Leukaemia Not Amenable to Allogeneic Hemopoietic Stem Cell Transplantation
Lead sponsor
Valerio Therapeutics
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2007
Completion date
April 30, 2009
Enrollment
10 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell chronic lymphocytic leukemia